EichorEICHOR
Location: Brisbane Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Brisbane

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Precision Medicine for Every Child With Cancer
Phase N/A · Queensland Children's Hospital · Australian & New Zealand Children's Haematology/Oncology Gro · NCT05504772A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Mater Misericordiae Limited · Eli Lilly and Company · NCT07218380AusCADASIL: An Australian Cohort of CADASIL
Phase N/A · Royal Brisbane and Women's Hospital · Perminder Sachdev · NCT06148051Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain
NA · Axxon Pain Medicine · Saluda Medical Pty Ltd · NCT04662905A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
Phase 2/Phase 3 · Queensland Children's Hospital · University of Birmingham · NCT05991388Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Royal Brisbane and Women's Hospital-Medical Oncology Clinica · Merck Sharp & Dohme LLC · NCT06393374A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Ramsay Clinic New Farm · Bristol-Myers Squibb · NCT06929273A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Gr
Phase 2 · Royal Brisbane and Women's Hospital /ID# 272123 · AbbVie · NCT06682988PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · Royal Brisbane and Women's Hospital · Boehringer Ingelheim · NCT07355296Phase 1a/1b Study of TRB-061 in Healthy Participants & Patients With Atopic Dermatitis
Phase 1 · TRex Bio, Inc. · NCT06934252A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au
Phase 3 · Local Institution - 0106 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07424404Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Amgen · NCT07037433A Platform Trial for Gram Negative Bloodstream Infections
NA · Sunnybrook Health Sciences Centre · NCT06537609Ultra-Early, Minimally inVAsive intraCerebral Haemorrhage evacUATion Versus Standard trEatment
NA · The Royal Brisbane and Women's Hospital · University of Melbourne · NCT04434807BMB-101 in Absence Epilepsy and DEE
Phase 2 · Bright Minds Biosciences Pty Ltd · NCT06401538A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Dia
Phase 3 · Centre for Children's Health Research · Eli Lilly and Company · NCT07222332A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
Phase 2 · Investigational Site Number: 0360002 · Sanofi · NCT06958536A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Phase 3 · Core Research Group · Eli Lilly and Company · NCT07369011A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
Phase 3 · Queensland Children's Hospital · Longboard Pharmaceuticals · NCT06660394Evaluation of the Safety, Tolerability and Pharmacokinetics of HY8931 in Healthy Adult Participants
Phase 1 · Q-Pharm Pty Ltd. · Newsoara Biopharma Co., Ltd. · NCT07281703ROADMAP Clinical Trial
Phase 4 · Mater Hospital Brisbane · University of Newcastle, Australia · NCT06771050Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
Phase 2/Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05948943Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003
Phase 1 · Mater Hospital Brisbane · PYC Therapeutics · NCT06714006Safety, Tolerability, and Pharmacokinetics of Multiple Dose Combinations of SION-451 and Complementary Modulators SION-2
Phase 1 · Nucleus Network · Sionna Therapeutics Inc. · NCT07035990Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Proto
Phase 3 · Wesley Medical Research · Tanabe Pharma America, Inc. · NCT05005975A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropath
Phase 3 · Biogen · NCT06962800A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metast
Phase 1/Phase 2 · Royal Brisbane and Women's Hospital-Medical Oncology Clinica · Merck Sharp & Dohme LLC · NCT05562830A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Boehringer Ingelheim · NCT07220083SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Phase 2 · Queensland Children's Hospital · SAb Biotherapeutics, Inc. · NCT07187531A Study of Intravenous CPTX2309 in Healthy Participants and Participants With Moderate to Severe Rheumatoid Arthritis (R
Phase 1 · Capstan Therapeutics · NCT06917742
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.